← Back to headlines
Invivyd Reports Positive Phase 3 Results for VYD2311 COVID-19 Treatment
Invivyd (IVVD) has announced favorable results from its Phase 3 analysis for VYD2311, a new treatment designed for COVID-19.
24 Apr, 19:14 — 24 Apr, 19:14
Sources
Showing 1 of 1 sources
